Am Fam Physician. 1999 Sep 15;60(4):1131-9.

Raloxifene: a selective estrogen receptor modulator.

Source

Duke/Southern Regional Area Health Education Center, Fayetteville, North Carolina 28304, USA.

Abstract

Raloxifene is a selective estrogen receptor modulator that produces both estrogen-agonistic effects on bone and lipid metabolism and estrogen-antagonistic effects on uterine endometrium and breast tissue. Because of its tissue selectivity, raloxifene may have fewer side effects than are typically observed with estrogen therapy. The most common adverse effects of raloxifene are hot flushes and leg cramps. The drug is also associated with an increased risk of thromboembolic events. The beneficial estrogenic activities of raloxifene include a lowering of total and low-density lipoprotein cholesterol levels and an augmentation of bone mineral density. Raloxifene has been labeled by the U.S. Food and Drug Administration for the prevention of osteoporosis. However, its effects on fracture risk and its ability to protect against cardiovascular disease have yet to be determined. Studies are also being conducted to determine its impact on breast and endometrial cancer reduction.

Comment in

Am Fam Physician. 1999 Sep 15;60(4):1092, 1095.

PMID:: 10507743; [PubMed - indexed for MEDLINE]

Free full text

LinkOut - more resources

Full Text Sources

Medical

Osteoporosis - MedlinePlus Health Information

Molecular Biology Databases

RALOXIFENE - HSDB

Supplemental Content

Icon for American Academy of Family Physicians

Save items

Related citations in PubMed

Review Clinical effects of raloxifene hydrochloride in women. [Ann Intern Med. 1999]
Review Clinical effects of raloxifene hydrochloride in women.
Khovidhunkit W, Shoback DM. Ann Intern Med. 1999 Mar 2; 130(5):431-9.
Review Raloxifene. [Drugs Aging. 1998]
Review Raloxifene.
Balfour JA, Goa KL. Drugs Aging. 1998 Apr; 12(4):335-41; discussion 342.
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. [JAMA. 1999]
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, et al. JAMA. 1999 Jun 16; 281(23):2189-97.
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. [JAMA. 1998]
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
Walsh BW, Kuller LH, Wild RA, Paul S, Farmer M, Lawrence JB, Shah AS, Anderson PW. JAMA. 1998 May 13; 279(18):1445-51.
Review Selective estrogen receptor modulators: an alternative to hormone replacement therapy. [Proc Soc Exp Biol Med. 1998]
Review Selective estrogen receptor modulators: an alternative to hormone replacement therapy.
Bryant HU, Dere WH. Proc Soc Exp Biol Med. 1998 Jan; 217(1):45-52.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Raloxifene: a selective estrogen receptor modulator.
Raloxifene: a selective estrogen receptor modulator.
Am Fam Physician. 1999 Sep 15 ;60(4):1131-9.

PubMed
The value of collaboration: quality improvement in critical care units.
The value of collaboration: quality improvement in critical care units.
Crit Care Med. 1999 Sep ;27(9):2034-5.

PubMed
Comparative pharmacology of bipolar disorder and schizophrenia.
Comparative pharmacology of bipolar disorder and schizophrenia.
Schizophr Res. 1999 Sep 29 ;39(2):153-8; discussion 163.

PubMed
Effectiveness of combining atypical antipsychotics and psychosocial rehabilitati...
Effectiveness of combining atypical antipsychotics and psychosocial rehabilitation in a community mental health center setting.
J Clin Psychiatry. 1999 ;60 Suppl 19:47-51; discussion 52-3.

PubMed
Dietary fat and carbohydrates are independently associated with circulating insu...
Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults.
J Clin Oncol. 1999 Oct ;17(10):3291-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Raloxifene: a selective estrogen receptor modulator.

Source

Abstract

Comment in

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information